Carcinoma of the anal canal: Results of the radical radiotherapy

From February 1995 to August 2001, 34 pts with squamous cell carcinoma of the anal canal (stage T2-35,3%, stage T3-44,1%, stage T4-20,6%, stage N1-29,4%) were treated prospectively by definitive radiotherapy only, delivered with megavoltage linear accelerator, combined with intracavitary brachytherapy in some patients, at the Institute for Oncology and Radiology of Serbia. Total tumor dose was range 55-75Gy. Median follow-up time was 24,7 months (range 6-66 months). Overall survival and disease free survival at 5 years were 65,44% and 68,44%. Local control was 82,3% (28/34 pts). Eight pts had local or distant failure. Early and late complication rates were acceptable. In majority of patients the anal sphincter function was preserved.